Design, synthesis and biological evaluation of selective hybrid coumarin-thiazolidinedione aldose reductase-II inhibitors as potential antidiabetics
作者:Vijay Kumar Pasala、Gopinath Gudipudi、Venu Sankeshi、Manohar Basude、Rambabu Gundla、Surendar singh Jadav、Burra Srinivas、E. Yadaiah Goud、Devasani Nareshkumar
DOI:10.1016/j.bioorg.2021.104970
日期:2021.9
Thiazolidinediones (TZD), benzopyrans are the proven scaffolds for inhibiting Aldose reductase (ALR2) activity and their structural confluence with the retention of necessary fragments helped in designing a series of hybrid compounds 2-(5-cycloalkylidene-2,4-dioxothiazolidin-3-yl)-N-(2-oxo-2H-chromen-3-yl)acetamide (10a-n) for better ALR2 inhibition. The compounds were synthesized by treating substituted
噻唑烷二酮 (TZD)、苯并吡喃是经过验证的抑制醛糖还原酶 (ALR2) 活性的支架,它们的结构融合与保留必要片段有助于设计一系列杂化化合物 2-(5-亚环烷基-2,4-二氧噻唑烷-3) -yl)-N-(2-oxo-2H-chromen-3-yl)acetamide ( 10a-n)可更好地抑制 ALR2。通过用 5-亚环烷基-1,3-噻唑烷-2,4-二酮 ( 4a-d ) 的钾盐处理取代的 3-( N-溴乙酰基氨基)香豆素 ( 9a-d ) 合成这些化合物。对 ALR2 的抑制活性的 IC 50值范围为 0.012 ± 0.001 至 0.056 ± 0.007 μM。 N-[(6-溴-3-香豆素基)-2-(5-亚环戊基-2,4-二氧噻唑烷-3-基)]乙酰胺(10c) ,一端带有亚环戊基,另一端带有6-溴基团end 对 ALR2 显示出更好的抑制特性 (IC 50 = 0.012 μM)